688535 华海诚科
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.3403.8784.50011.41220.893
总资产报酬率 ROA (%)0.9743.0433.6458.22811.473
投入资产回报率 ROIC (%)1.0983.4394.33811.39217.821

边际利润分析
销售毛利率 (%)26.40925.63426.88027.00729.142
营业利润率 (%)8.45612.19111.04113.71514.834
息税前利润/营业总收入 (%)10.19013.77011.98314.26016.580
净利润/营业总收入 (%)7.62112.04211.18413.59613.746

收益指标分析
经营活动净收益/利润总额(%)-19.28129.26046.38884.97391.302
价值变动净收益/利润总额(%)83.29245.93141.1813.729-0.375
营业外收支净额/利润总额(%)-0.5937.7127.5521.1844.165

偿债能力分析
流动比率 (X)1.5831.8741.8592.9812.670
速动比率 (X)1.2271.4431.3962.4092.183
资产负债率 (%)28.61825.90116.51425.08930.772
带息债务/全部投入资本 (%)16.91914.5161.983-2.802-2.837
股东权益/带息债务 (%)477.299572.5234,797.307-3,568.677-3,511.414
股东权益/负债合计 (%)249.385286.010505.565298.585224.973
利息保障倍数 (X)5.71324.602299.69637.42915.051

营运能力分析
应收账款周转天数 (天)141.210137.360151.918136.758104.492
存货周转天数 (天)114.368118.638127.137110.09976.101